University of Central Florida BEEAST

March 24, 2025 updated by: University of Central Florida

University of Central Florida Biobank for Extreme Environments, Aviation and Space Travel

Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).

Study Overview

Status

Recruiting

Conditions

Detailed Description

The objective of the University of Central Florida College of Medicine's Biobank for Extreme Environments, Aviation and Space Travel (BEEAST) is to acquire, store, and distribute identifiable human biospecimens and health information for medical research purposes only. The target population are astronauts, aviators, submariners, persons living in extreme environments (such as Antarctica), and their families, and people from the general population who can serve as matching controls.

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Florida
      • Orlando, Florida, United States, 32827
        • Recruiting
        • University of Central Florida
        • Contact:
        • Contact:
        • Contact:
          • Emmanuel Urquieta, MD, MA, FAsMA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The target population comprises of persons from many countries. Therefore, enrollees can be from other countries. However, biospecimen collection will occur in the USA.

Description

Inclusion Criteria:

  • Primary Enrollees: adults, ages 18 and older, and persons who travel (such as space travel) or live in extreme environments (such as Antarctica).
  • Secondary Enrollees: Referred adult family members (such as siblings and spouses) of primary enrollees.
  • Tertiary Enrollees: Adult persons from the general public can enroll to serve as matching controls. Tertiary enrollees will be screened based on age, gender, race and ethnicity, country of residence, disease/ conditions and employment history.
  • Pregnant women may choose to enroll.

Exclusion Criteria:

  • adults unable to consent,
  • minors (under age 18)
  • prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Primary Partcipant
Participants who have who travel (such as space travel) or live in extreme environments (such as Antarctica).
Secondary Participant
Participants who have been referred adult family members (such as siblings and spouses) of primary enrollees.
Tertiary Partcipant
Participants from the general public to serve as matching controls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Receipt of donated biospecimen for aerospace research
Time Frame: 50 years
Donated biospecimens from participants will aid in the improvement of medical aerospace research. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
50 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Central Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2025

Primary Completion (Estimated)

January 13, 2075

Study Completion (Estimated)

January 13, 2075

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 13, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 26, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • STUDY00007332

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biospecimen Donation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe